Colleen Doyle Cooper

Principal investigator.

Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$5.5MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20222026
AwardsPatents
Federal awards as principal investigator

8 awards · $5.5M

DateAgencyAwardAmountCompany
Aug 28, 2026NIHSBIR Phase I
Development of a Novel, Allogeneic Cell Therapy for Difficult to Treat IBD
$356KCELDARA MEDICAL, LLC
Aug 24, 2026NIHSBIR Phase I
Precision CAR-NK therapy for VK4-1 autoreactive B cells in autoimmune diseases: advancing treatment with preserved immune function.
$321KCELDARA MEDICAL, LLC
May 26, 2026NIHSBIR Phase II
Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma
$1.0MCELDARA MEDICAL, LLC
Dec 24, 2024NIHSBIR Phase II
Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma
$1.2MCELDARA MEDICAL, LLC
May 16, 2024NIHSBIR Phase II
Development of CM-IAV1 for Treatment of High-risk Pandemic Influenzas
$998KCELDARA MEDICAL, LLC
Jun 12, 2023NIHSBIR Phase II
Preclinical development of an important, broad-spectrum antibody for pandemic influenza
$1000KCELDARA MEDICAL, LLC
Aug 9, 2022NIHSBIR Phase I
Development of a broad spectrum antimicrobial to combat chronic lung infection
$301KCELDARA MEDICAL, LLC
Apr 25, 2022NIHSBIR Phase II
Development of CM-IAV1 for Treatment of High-risk Pandemic Influenzas
$300KCELDARA MEDICAL, LLC
Among 4,078 researchers in Biotech

Peer ranks

Federal funding#228
Awards as PI#190
Patents#273
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.